Screener / SEC EDGAR /CIK 0000730464 /10-K filed Aug 6, 2026, compared with Aug 7, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Consumer discretionary · Educational Services

Covista Inc. CVSA

Compare with peers Embed
SEC comment letters, last 20 years

5 reviews of CVSA's filings by SEC staff

UPLOAD and CORRESP
Reviews 5 latest letter Feb 10, 2025
Questions asked 11 each answered in the company's own letter
No closing letter 0 reviews without a letter saying the staff completed it

When the SEC's staff reviews a filing, it writes to the company with numbered questions, and the company answers each one in a letter. SEC publishes the exchange once the review is over, at least 20 business days later. A question is not an accusation; most reviews end with the company adding detail to its next filing.

How the reviews went

Every review on EDGAR, from the first staff letter to the letter that closes it

  1. 1. Staff letters 6 UPLOAD
  2. 2. Questions in them 11 numbered comments
  3. 3. Company replies 5 CORRESP
  4. 4. Reviews closed 5 of 5 closing letter

Half the closed reviews took 22 days or less from the first letter to the closing letter.

Form 10-K

2025-02-10 to 2025-03-04 · 1 question · 1 letter from the SEC, 1 from the company
Review closed 2025-03-04
RevenueControls
Controls and Procedures · Evaluation of Disclosure Controls and Procedures, page 102
SEC asked
You disclose on page 67 that you identified an error in the presentation of capitalized cloud computing implementation costs in your previously issued financial statements. In your fiscal year ended June 30, 2023, Form 10-K, you disclose that you identified an error in your previously issued financial statements related to revenue recognition for certain scholarship programs.
Rest of the question

Please tell us what impact, if any, the errors had on your conclusions regarding effectiveness of your Disclosure Controls and Procedures and your Internal Control over Financial Reporting for each affected period.

CVSA answered
During the fiscal year ended June 30, 2023 (fiscal year 2023), we identified an error relating to revenue recognition for certain scholarship programs in our previously issued financial statements, and during the fiscal year ended June 30, 2024 (fiscal year 2024), we identified an error in the presentation of capitalized cloud computing implementation costs in our previously issued financial statements.
Rest of the answer

For each of these errors identified, we analyzed the root cause of the control deficiency that led to the error and evaluated the severity of the control deficiency, both individually and in the aggregate, based on the SEC’s Guidance Regarding Management’s Report on Internal Control Over Financial Reporting Under Section 13(a) or 15(d) of the Securities Exchange Act of 1934. In performing our evaluation of the severity of each of the control deficiencies, we evaluated whether there is a reasonable possibility that the

Company’s Internal Control over Financial Reporting (“ICFR”) will fail to prevent or detect a misstatement of a financial statement amount or disclosure; and the magnitude of the potential misstatement resulting from the deficiency. Based on the evaluation of the deficiencies, as further described below, we concluded the deficiencies did not rise to the level of a material weakness, either individually or in the aggregate, and that our Disclosure Controls and Procedures (“DCP”) and our ICFR were effective as of June 30, 2023 and June 30, 2024, respectively.

For the revenue recognition error identified in fiscal year 2023, we noted that the error was isolated to certain scholarship programs only offered within our Medical and Veterinary segment. Furthermore, those scholarships were only issued at scale beginning in fiscal year 2021 in response to competitive pressures faced specifically by our medical universities and therefore the error only impacted fiscal years 2021, 2022 and 2023. We determined that the control deficiency that led to the error is a design deficiency due to the lack of an effectively designed control to verify that the material right guidance in ASC 606 was applied for Medical and Veterinary segment scholarship programs. In evaluating the severity of the deficiency, we assessed the magnitude of the potential misstatement that could result from the deficiency, specifically considering the following:

● The deficiency is specific to the lack of an effectively designed control activity related to scholarship programs in the Medical and Veterinary segment and is not pervasive in nature (i.e., the deficiency does not impact other aspects of the Medical and Veterinary segment, nor does it impact transactions outside of the Medical and Veterinary segment).

● Whether these types of scholarships have been or would be issued in our other segments. These types of scholarships have not previously been and would not be issued in our other segments given the nature of those schools and profile of their students. This is due to the nature of the programming, the cost of tuition and the purpose of the incentive offered with such scholarship programs in the Medical and Veterinary segment. Therefore, we concluded the potential misstatement that could result from the deficiency would only impact scholarship programs in the Medical and Veterinary segment.

● Whether the potential misstatement that could result from the deficiency could be larger than the actual error that occurred in the Medical and Veterinary segment. We concluded it is not reasonably possible that the potential misstatement could be larger than the actual error that occurred given the student populations in the Medical and Veterinary segment are relatively constant year over year. Given the nature of the Medical and Veterinary segment educational experience (e.g., in person), substantial growth beyond current levels would necessitate investment in, among other things, expanded facilities and increased faculty with appropriate professional qualifications. No such efforts are planned for the foreseeable future. Additionally, these scholarship programs were the result of competitive pressures faced specifically by our medical universities starting in fiscal year 2021.

Based on the aforementioned considerations, and the consideration of qualitative factors, including whether indicators of a material weakness are present, the magnitude of the potential misstatement that is at least reasonably possible is not material to either the interim or annual financial statements. Therefore, we concluded the control deficiency does not rise to the level of a material weakness.

For the error in the presentation of capitalized cloud computing implementation costs, we noted that the error was isolated to information technology (“IT”) projects in fiscal year 2023 and 2024 that were identified under our Growth with Purpose (“GWP”) program to support institutional growth and optimize business processes. In pursuing those projects, it was determined that implementing cloud platforms provided us the ability to move quickly in support of our growth efforts, and as a result we pursued significant IT investments specifically in cloud platforms. Prior to this program, we did not have significant investments in cloud platforms, and therefore did not need controls to delineate between implementation costs associated with cloud platforms versus internally developed software. This resulted in the presentation error being limited to the IT projects pursued and capitalized during fiscal year 2023 and 2024. We determined that the control deficiency that led to the error is a design deficiency due to the lack of an effectively designed control to verify the appropriateness of the classification and presentation of capitalized cloud computing implementation costs. In evaluating the severity of the deficiency, we assessed the magnitude of the potential misstatement that could result from the deficiency, specifically considering the following:

● The deficiency is not pervasive in nature and is specific to the lack of an effectively designed control activity related to the classification and presentation of capitalized cloud computing implementation costs. The deficiency does not impact the determination of what costs to capitalize as the Company’s legacy processes were designed effectively and operated as intended given that ASU 2018-15 stipulates that both internal-use software projects and cloud computing projects follow the same accounting model when determining which implementation costs are eligible for capitalization.

● The potential misstatement that could result from the deficiency and whether it could be significantly larger than the actual error that occurred. Given the Company began the strategic initiatives to standardize its IT operations through cloud platforms under its GWP program discussed above in 2023, we identified all software projects initiated in fiscal year 2023 and 2024 to determine the costs within those projects that represent cloud computing implementation costs versus those costs that relate to internal-use software. We also separately analyzed how the Company’s IT strategy is employed to evaluate what percentage of IT development costs are potentially cloud computing in nature versus internal-use software in nature. We then took that percentage of cloud computing implementation costs and applied it to the total IT development costs to determine the potential misstatement that could result from the control deficiency. Based on our project by project review, and the separate additional analysis, we concluded that the potential misstatement that could result from the control deficiency was not material.

Based on the aforementioned considerations, and the consideration of qualitative factors, including whether indicators of a material weakness are present, the magnitude of the potential misstatement that is at least reasonably possible is not material to either the interim or annual financial statements. Therefore, we concluded the control deficiency does not rise to the level of a material weakness.

We also considered if the deficiencies that led to the errors were an indication of a broader control deficiency, specifically with respect to competency associated with the application of generally accepted accounting principles in the U.S., whether there were any implications to the period-end financial reporting process, as well as other components of the Committee of Sponsoring Organizations of the Treadway

Commission framework such as risk assessment or information and communication. Given the differing root causes of the deficiencies, the fact that each relates to a specific aspect within an individual business process, and the fact that the deficiencies are not pervasive in nature, we concluded the deficiencies were not indicative of a broader deficiency in ICFR or DCP.

We discussed these conclusions with the CEO, CFO, our internal Disclosure Committee and the Audit and Finance Committee of the Adtalem Board of Directors at those times.

The Company acknowledges that the accuracy and adequacy of the disclosures in its filing with the Commission are the responsibility of the Company. We appreciate the Staff’s assistance in this process and would be pleased to discuss with you any additional comments the Staff may have.

Read in the reply
In its next report

First report after the company's reply of Feb 20, 2025: 10-Q filed May 8, 2025 ↗, against the 10-Q filed Jan 30, 2025 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Also in this review: closing letter, 2025-03-04

Form 10-K

2023-04-21 to 2023-05-15 · 1 question · 1 letter from the SEC, 1 from the company
Review closed 2023-05-15
Non-GAAP measuresResults discussion (MD&A)
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations · Non-GAAP Financial Measures and Reconciliations, page 78
SEC asked
Refer to your non-GAAP financial measures Net income from continuing operations excluding special items, Earnings per share from continuing operations excluding special items, and Operating income excluding special items. It appears that the reconciliations for these non-GAAP financial measures include an adjustment for"restructuring expense" which you have incurred every year since 2012.
Rest of the question

Please tell us your consideration as to whether these charges represent normal, recurring, cash operating expenses necessary for your core operations. Refer to Question 100.01 of the Compliance and Disclosure Interpretations on Non-GAAP Financial Measures. Please note that this comment also applies to the non-GAAP measures presented in your Form10-Q and Item 2.02, Form 8-K. In closing, we remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

CVSA answered
We provide investors with non-GAAP financial measures that we believe are useful supplemental information regarding the underlying business trends and performance of our ongoing operations as seen through the eyes of management and are useful for period-over-period comparisons. These supplemental non-GAAP financial measures are used internally in our assessment of performance, our budgeting process, and in defining target metrics for our management compensation plans.
Rest of the answer

While we believe these metrics are useful supplemental information, we highlight in our disclosures that the non-GAAP financial measures presented should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. In providing non-GAAP financial measures, we acknowledge the authoritative guidance regarding the use of non-GAAP Financial measures in Regulation G, S-K Item 10(e) and Instruction 2 to Item

2.02, in addition to the Staff’s Compliance and Disclosure Interpretations on Non-GAAP Financial Measures, specifically Question 100.1. In accordance with that guidance, we do not include adjustments for items that we may believe represent normal, recurring, cash operating expenses necessary for our core operations.

With specific regards to our adjustment for restructuring expense, we present within that adjustment exit costs that are in accordance with the guidance in Staff Accounting Bulletin (“SAB”) No. 100 –

Restructuring and Impairment Charges and that meet all of the following conditions:

a.

The cost is not associated with or does not benefit activities that will be continued b.

The cost is not associated with or is not incurred to generate revenues after the commitment date c.

The cost meets one of the following criteria:

i.

It is incremental to other costs incurred in the company’s conduct of its activities prior to the commitment date and will be incurred as a direct result of the exit plan; or ii.

The cost will be incurred under a contractual obligation that existed prior to the commitment date and will either continue after the exit plan is completed with no economic benefit to the company or be a penalty to cancel the contractual obligation

Consistent with the guidance in SAB No. 100, we present within restructuring expense exit costs that are in scope of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 420, Exit or Disposal Cost Obligations, and therefore restructuring expense relates to one of the following transactions or activities:

Termination benefits provided to current employees that are involuntarily terminated under the terms of a benefit arrangement that, in substance, is not an ongoing benefit arrangement or an individual deferred compensation contract (referred to as one-time employee termination benefits)

Costs to terminate a contract that is not a capital lease

Costs to consolidate facilities or relocate employees d.

Costs associated with a disposal activity e.

Costs associated with an exit activity, including exit activities associated with an entity newly acquired in a business combination or an acquisition by a not-for-profit entity.

Per the above guidance, we do not include costs that may represent normal, recurring, cash operating expenses necessary for our core operations, but instead present costs within restructuring expense that relate to specific actions to exit certain activities that will not be continued, and those costs are incremental to those necessary for our core operations. Costs included within restructuring expense include employee severance and compensation benefits paid as part of workforce reductions, impairment charges (including impairments of operating lease assets) relating to campus and administrative office consolidations where the underlying assets will not be used as part of ongoing operations, and any contract costs that relate to a preexisting contractual obligation that existed prior to the commitment date of our exit decision and relate to items that will no longer be used in our ongoing operations.

As the Staff has noted, we have presented restructuring expense as an adjustment within our non-GAAP financial measures since fiscal year 2012. This is due to the various exit decisions made since that time, which resulted in us incurring exit costs that were incremental to our core operations and did not benefit future core operations.

In fiscal year 2012, we were experiencing declines in student enrollments at DeVry University and Carrington College and therefore made decisions to begin the process of exiting certain markets and align our cost structure to correspond with these declining enrollments. Given the nature of our business operations, we are unable to immediately cease offering instruction and shut down campus facilities, as we have an obligation to provide education to existing students and therefore must exercise care in when we execute workforce reductions and real estate consolidations. As a result, starting in fiscal year 2012, we strategically staggered our exit activities over subsequent fiscal years to allow for a methodical shut down of operations in the applicable markets in alignment with when students were completing their education. Therefore, we continued to incur restructuring expense relating to these exit activities through fiscal year 2017 which corresponded with further declines in enrollments at each of the institutions. In fiscal year 2017, after further deterioration in student enrollment trends at DeVry University and Carrington College, we made the decision to sell those institutions. As we worked on executing the sale of those institutions, we continued to incur exit costs relating to workforce reductions and real estate consolidations that were classified as restructuring expense during fiscal year

2017 and 2018. This continued through the completion of the sale of those institutions in fiscal year 2019.

In fiscal year 2018, we experienced significant damage to our campuses of the Ross University School of Medicine (“RUSM”) in Dominica due to Hurricane Maria and while we navigated business disruptions during that fiscal year (costs for which were not presented within restructuring since they related to core operations), in fiscal year 2019 we decided to cease RUSM operations in Dominica given the hurricane impacts and relocate RUSM operations to Barbados. As a result, we incurred exit costs relating to workforce reductions and asset impairments relating to our Dominica operations, and these costs were presented as restructuring expense.

During fiscal year 2019 and 2020, we consolidated office locations across our operations to rationalize and streamline our real estate footprint, and as a result incurred exit costs relating to office closures and impairments of the associated assets. During fiscal year 2021, these office closures were accelerated due to the COVID-19 pandemic and therefore we continued to incur additional office closure costs along with related impairment changes in that period. These exit costs were presented as restructuring expense in the relevant periods.

During fiscal year 2022, we acquired Walden University in the first quarter of fiscal year 2022, and subsequently completed the sale of our operations within the Financial Services segment during the third and fourth quarter of fiscal year 2022. As a result of those strategic transactions, we reorganized our operations across the existing businesses and therefore incurred exit costs relating to workforce reductions, and office closures along with related asset impairment charges. The resulting exit costs were presented as restructuring expense in that period.

As we have described above, we do not believe the costs presented within restructuring expense relate to normal, recurring, cash operating expenses necessary for our core operations. As such, we believe adjusting for restructuring expense within our non-GAAP financial measures provides useful supplemental information regarding the underlying business trends and performance of our ongoing core operations as seen through the eyes of management and are useful for period-over-period comparisons. However, we acknowledge that we have had a series of exit actions over the years given all the strategic changes in our operations, and we note that for any current or future restructuring activities, we will provide additional disclosure in the MD&A non-GAAP section to clarify that these costs are not normal, recurring expenses necessary for our core operations.

The Company acknowledges that the accuracy and adequacy of the disclosures in its filing with the Commission are the responsibility of the Company. We appreciate the Staff’s assistance in this process and would be pleased to discuss with you at your earliest convenience any additional comments the Staff may have.

Read in the reply
In its next report

First report after the company's reply of May 3, 2023: 10-K filed Aug 10, 2023 ↗, against the 10-K filed Aug 11, 2022 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Also in this review: closing letter, 2023-05-15

Form 10-K for the Fiscal Year Ended June 30, 2019

2020-04-03 to 2020-05-08 · 4 questions · 2 letters from the SEC, 1 from the company
Review closed 2020-05-08
Results discussion (MD&A)Liquidity and cashDebtRevenue
SEC letter of Apr 3, 2020 ↗ no reply letter on EDGAR
Operations · Other Contractual Arrangements, page 74
SEC asked (1)
It appears the cash interest payments on your debt obligations may represent a material contractual obligation. Because this table is aimed at increasing transparency of cash flow, we believe these payments should be included in the table or disclosed in the footnotes using the same time frames stipulated in the table. Please also disclose any assumptions you made to derive these amounts.
Rest of the question

If you choose not to include these payments, a footnote to the table should clearly identify the excluded item and provide any additional information that is material to an understanding of your cash requirements. Refer to Item 303(a)(5)303(a)(5) of Regulation S-K and footnote 46 to SEC Release No. 33-8350.

CVSA answered

No reply letter found.

In its next report

First report after the SEC's letter of Apr 3, 2020: 10-Q filed May 5, 2020 ↗, against the 10-Q filed Feb 4, 2020 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 4. Summary of Significant Accounting Policies · Revenue Recognition , page 88
SEC asked (2)
We note that for Becker test preparation revenue is recognized when access to the course materials is delivered to the customer and that for Adtalem Brazil and EduPristine test preparation course instruction revenue is recognized on a straight-line basis over the applicable instruction delivery periods.
Rest of the question

Please tell us in further detail why the revenue recognition method for the test preparation services differs between Becker and Adtalem Brazil and EduPristine. In this regard, we note from the Becker website that Premium and Pro packages include various live online and/or live courses, success coaching, and personal tutoring in addition to pre-packaged course materials.

CVSA answered

No reply letter found.

In its next report

First report after the SEC's letter of Apr 3, 2020: 10-Q filed May 5, 2020 ↗, against the 10-Q filed Feb 4, 2020 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Operations · Other Contractual Arrangements, page 74
SEC asked (1)
It appears the cash interest payments on your debt obligations may represent a material contractual obligation. Because this table is aimed at increasing transparency of cash flow, we believe these payments should be included in the table or disclosed in the footnotes using the same time frames stipulated in the table. Please also disclose any assumptions you made to derive these amounts.
Rest of the question

If you choose not to include these payments, a footnote to the table should clearly identify the excluded item and provide any additional information that is material to an understanding of your cash requirements. Refer to Item 303(a)(5)303(a)(5) of Regulation S-K and footnote 46 to SEC Release No. 33-8350.

CVSA answered
The contractual arrangements disclosed in Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Form 10-K for the fiscal year ended June 30, 2019 filed on August 28, 2019 disclosed the principal payments on our long-term debt obligations but did not include the cash interest payments on our long-term debt obligations. We are happy to include cash interest payments within this disclosure in future filings to more clearly comply with Item 303(a)(5) of Regulation S-K and SEC Release No. 33-8350.
Rest of the answer

We are providing below an example of our intended future disclosure which includes cash interest payments on our long-term debt obligations by providing what our contractual obligations disclosure would have been as of June 30, 2019 with this information included.

Our contractual obligations as of June 30, 2019 were as follows (in thousands):

Due In

Less Than

After

All

Total

1 Year

1-3 Years

4-5 Years

5 Years

Other

Long-term debt

$

407,000

3,000

6,000

116,000

282,000

—

Interest on long-term debt (1)

90,234

15,984

31,482

30,834

11,934

Operating leases

405,430

86,010

149,802

98,749

70,869

Deferred purchase price agreements

16,444

6,794

9,650

Employment agreements

769

415

354

Transition tax

8,729

310

2,848

5,571

Uncertain tax positions

36,182

964,788

112,203

197,598

248,431

370,374

(1) Interest payment obligations on our long-term debt are estimated by assuming the interest rates in effect as of June 30, 2019 under our Credit Facility will remain constant in the future and the principal amounts outstanding will be repaid at the dates represented in the long-term debt disclosure within this table and discussed in Note 13 “Debt” to the

Consolidated Financial Statements. Actual future interest payments will vary from this estimated disclosure based on changes in interest rates and amounts borrowed.

Read in the reply
In its next report

First report after the company's reply of Apr 23, 2020: 10-Q filed May 5, 2020 ↗, against the 10-Q filed Feb 4, 2020 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 4. Summary of Significant Accounting Policies · Revenue Recognition , page 88
SEC asked (2)
We note that for Becker test preparation revenue is recognized when access to the course materials is delivered to the customer and that for Adtalem Brazil and EduPristine test preparation course instruction revenue is recognized on a straight-line basis over the applicable instruction delivery periods.
Rest of the question

Please tell us in further detail why the revenue recognition method for the test preparation services differs between Becker and Adtalem Brazil and EduPristine. In this regard, we note from the Becker website that Premium and Pro packages include various live online and/or live courses, success coaching, and personal tutoring in addition to pre-packaged course materials.

CVSA answered
ASC 606-10-50-5 requires an entity to disaggregate revenue recognized from contracts with customers into categories that depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. We provide a disaggregation of our revenue by type of good or service (major product line). We provide our performance obligations and revenue recognition policies for each category used in this disaggregation of revenue presentation, with Test Preparation being one of those categories.
Rest of the answer

Becker Professional Education (“Becker”), Adtalem Education of Brazil (“Adtalem Brazil”), and EduPristine each have operations, or portions of their operations, that generate revenue that we classify within the Test Preparation category. The test preparation products offered by Becker are significantly different from the products offered by Adtalem

Brazil and EduPristine, resulting in different revenue recognition methods. Becker and EduPristine are reported within our Financial Services segment and Adtalem Brazil was reported within our former Business and Law segment.

Becker develops proprietary course materials that have been widely used by CPA exam candidates to prepare for the CPA exam for decades. While

Becker offers a variety of packages and products, the primary product is the pre-packaged, self-study course materials. All Becker CPA review packages have the self-study materials as the core product offering and these materials are the principal revenue source for Becker’s test preparation business. Revenue generated at Becker from non-self-study materials is less than one percent of Adtalem consolidated revenue. Based on our analysis of the guidance in ASC 606-10-25-30, pre-packaged, self-study course materials sales are recognized as revenue at the point in time when access to the course materials is delivered to the customer.

Adtalem Brazil acquired Damásio Educacional (“Damasio”) in February 2015. Damasio operates a law school and offers bar exam test preparation and other exam review courses. The bar and other exam review products are classified as Test Preparation revenue within our disaggregation of revenue disclosures. Adtalem Brazil acquired São Judas Tadeu (“SJT”) in November 2017. SJT’s revenue source is a medical doctor specialty test preparation review. Damasio’s bar and other exam test preparation products and SJT’s product represents all of Adtalem Brazil’s test preparation offerings. The test preparation offerings at Adtalem Brazil are delivered primarily in the form of live or live-online instruction with sales of self-study course materials representing less than one percent of Adtalem consolidated revenue. Based on our analysis of the guidance in ASC 606-10-25-27, the revenue from instruction is recognized over the applicable instruction delivery periods.

EduPristine has been consolidated in Adtalem’s consolidated financial statements since March 2018 when Adtalem achieved a 69% ownership interest in EduPristine. EduPristine offers test preparation services in the form of online and classroom instruction for several professional areas. EduPristine’s test preparation offerings are predominately in the form of live instruction. Based on our analysis of the guidance in ASC 606-10-25-27, the revenue from instruction is recognized over the applicable instruction delivery periods.

We focused our test preparation revenue recognition policy disclosures on the most significant drivers of revenue for each business. It was our judgment, consistent with the guidance in ASC 606-10-50-1 and ASC 606-10-50-2, that providing sufficient information is important to enable users of financial statements to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers by limiting disclosures to a level of detail necessary to achieve this objective so that useful information is not obscured by the inclusion of a large amount of insignificant detail.

To specifically address the Staff’s comments on the information on Becker’s website concerning Premium and Pro packages, which include various live-online and/or live courses, success coaching, and personal tutoring, Becker often markets various packages to attract customers. These packages offered to customers may change based on marketing strategies. All Becker CPA review packages have the self-study materials as the core product offering and these materials are the primary revenue source for Becker’s test preparation business. As noted above, revenue generated at Becker from non-self-study materials is less than one percent of Adtalem consolidated revenue. For this reason and based on our judgments discussed above, we only included discussion on the self-study course materials. Given the Staff’s comments, below is an example of our future disclosure that will clarify our test preparation revenue recognition policy to provide the user of the financial statements a better understanding of why the revenue recognition timing is different between these businesses. We intend to include this language in the notes to the financial statements in future filings.

Test preparation revenue consists of sales of self-study materials and test preparation course instruction. Becker test preparation revenue is primarily derived from self-study materials and is recognized when access to the materials is delivered to the customer. Adtalem Brazil and EduPristine test preparation revenue is primarily derived from course instruction and is recognized on a straight-line basis over the applicable instruction delivery period.

The Company acknowledges that the accuracy and adequacy of the disclosures in its filing with the Commission are the responsibility of the

Company. We appreciate the Staff’s assistance in this process and would be pleased to discuss with you at your earliest convenience any additional comments the Staff may have.

Read in the reply
In its next report

First report after the company's reply of Apr 23, 2020: 10-Q filed May 5, 2020 ↗, against the 10-Q filed Feb 4, 2020 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Also in this review: closing letter, 2020-05-08

Form 10-K for the Fiscal Year Ended June 30, 2017

2018-03-28 to 2018-04-12 · 3 questions · 1 letter from the SEC, 1 from the company
Review closed 2018-04-12
RevenueLiquidity and cash
Medical and Veterinary Schools · Medical and Veterinary Schools Student Enrollment, page 43
SEC asked (1)
We note the 11.5% increase in the number of students enrolled in your medical and veterinary schools. Expand your discussion to address the reasons underlying the increase and disclose whether management views this as a known trend that is likely to continue. Refer to SEC Release No. 33-8350.
CVSA answered
We are providing an example of our future disclosures based upon the language in our most recent filing to be responsive to the SEC's comments regarding the Medical and Veterinary Schools revenue discussion from the Management’s Discussion and Analysis (“MD&A”) section. We intend to include similar language in our MD&A disclosures in future filings when detailed analysis of enrollment trends is necessary to comply with SEC Release No. 33-8350.

Medical and Veterinary Schools Student Enrollment:

Fiscal Year 2018

Term

Sept. 2017

Jan.
Rest of the answer

2018

New Students

812

515

% Change from Prior Year

0.7%

11.5%

Total Students

5,744

5,938

(6.9%)

1.3%

Fiscal Year 2017

Sept. 2016

Jan. 2017

May 2017

806

462

458

(18.7%)

(10.8%)

(14.4%)

6,168

5,863

5,491

(5.8%)

(8.0%)

(6.1%)

Hurricanes Irma and Maria affected student enrollment in fiscal year 2018 at the American University of the Caribbean School of Medicine (“AUC”) and Ross University School of Medicine (“RUSM”, collectively the “medical schools”). The medical schools experienced combined decreases in new student and total student enrollment of 3.8% and 10.4%, respectively, in the September 2017 semester compared to the September 2016 semester. These decreases were offset by increases in new student and total student enrollment of 4.4% and 1.4%, respectively, at Ross University School of Veterinary Medicine (“RUSVM”). The principal driver of the decrease in medical school enrollment in the September 2017 semester was the disruption caused by the hurricanes. Some new students delayed entry and a number of returning students took a leave of absence in this semester. A significant number of these students then returned for the January 2018 semester, in which the medical schools’ combined new and total enrollment increased 26.0% and 1.2%, respectively, compared to the January 2017 semester. The medical schools’ new student enrollment increase for the first two semesters of fiscal year 2018 was 4.4% compared to the first two semesters of fiscal year 2017. The new enrollment increase at the medical schools in the January 2018 semester was partially offset by a decrease in new student enrollment of 4.3% at RUSVM compared to the January 2017 semester. Management believes the demand for medical and veterinary education remains strong and can support management’s longer-term expectations to grow new enrollments in the low-single digit range; however, heightened competition may adversely affect the medical and veterinary schools’ ability to continue to attract qualified students to its programs.

The medical and veterinary schools revenue decreased 0.3%, or $0.3 million, to $88.2 million in the second quarter and decreased 6.4%, or $11.2 million, to $165.6 million in the first six months of fiscal year 2018 compared to the year-ago periods. The declines were driven primarily by revenue loss of approximately $0.9 million and $8.2 million, for the second quarter and first six months of fiscal year 2018, respectively, due to the effects of the hurricanes. These events forced postponements of the September 2017 semester basic science academic instruction at the medical schools, along with students withdrawing due to these disruptions. In addition, enrollment declines at the medical schools in the May 2017 semester, which contributed revenue for the first two months of fiscal year 2018, resulted in decreased revenue. These enrollment declines were partially offset by tuition price increases at AUC and RUSM for the September 2017 semester, as well as enrollment increases at RUSVM. Management is executing its plan to differentiate the medical and veterinary schools from the competition, with a core goal of increasing international students, and improving the effectiveness of marketing strategies by restructuring the marketing organization, and shifting from traditional media and event-driven marketing to greater use of digital and social media channels to drive awareness throughout the year. These strategies were successful and were responsible for the new student enrollment increases in the combined September 2017 and January 2018 semesters. Combining these semesters in our analysis is necessary due to the hurricane timing effect on new student enrollment as noted above.

Tuition Rates:

·

Effective for semesters beginning in September 2017, tuition rates for the beginning basic sciences and final clinical rotation portions of AUC’s medical program are $21,695 and $24,272, respectively, per semester. These tuition rates represent a 3.5% increase over the prior academic year.

Effective for semesters beginning in September 2017, tuition rates for the beginning basic sciences and Internal Medicine Foundations/final clinical portion of the programs at RUSM are $22,345 and $24,660, respectively, per semester. These tuition rates represent a 4.8% increase over the prior academic year.

Effective for semesters beginning in September 2017, tuition rates for the basic sciences and final clinical portion of the programs at RUSVM are $18,310 and $22,985, respectively, per semester. These tuition rates are unchanged from the prior academic year.

The respective tuition rates for AUC, RUSM and RUSVM do not include the cost of transportation, living expenses or health insurance.

Read in the reply
In its next report

First report after the company's reply of Apr 11, 2018: 10-Q filed May 3, 2018 ↗, against the 10-Q filed Feb 6, 2018 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Liquidity and Capital Resources · Financial Aid, page 53
SEC asked (2)
In order to provide context for investors, please: • Consider providing a brief overview of the Department of Education's gainful employment regulations, including a description of the framework and the methodology for calculating each of the three measures of accountability. • Identify your programs that fall into the failing category and the zone category.
Rest of the question

Disclose the percentage of your students currently enrolled in each program and the total revenues derived from the respective programs. • Expand your discussion of the adjustments or initiatives you plan to implement in efforts to bring these programs into the "pass" category. Specify the measures you plan to take and, if material, disclose the anticipated cost to modify these programs. We note that you expect "certain" programs will be able to avoid falling into the zone or failing categories in the future through adjustments to program price or duration.

CVSA answered
Prior to our most recent Form 10-K for the Fiscal Year Ended June 30, 2017, we provided additional disclosure regarding gainful employment regulations and its potential impact. Since most actions had been taken to address the potential impact of gainful employment and the U.S. Department of Education had announced a rulemaking process to replace the regulation, we removed this added background from our most recently filed Form 10-K and Form 10-Q. We will reinstate an updated version of this disclosure in future filings, and provide further detail and updates on a program level.
Rest of the answer

Below is an example of our future disclosures that also sets forth programs that will be or have ended in response to gainful employment considerations. With the exception of the potential impact that the current gainful employment regulations may have on Ross University School of Veterinary Medicine (“RUSVM”), actions taken to address the potential impact of gainful employment regulations have been substantially completed. We intend to include this language in the MD&A, Liquidity and Capital Resources disclosures in future filings.

U.S. Department of Education (“ED”) regulations known as its “gainful employment” regulations (“GE”), which became effective July 1, 2015 define which private-sector programs prepare students for gainful employment in a recognized profession and are therefore eligible for Title IV funding. ED has since announced a negotiated rulemaking process on June 16, 2017 to substantially revise the GE regulations and held rulemaking sessions in December 2017 and March 2018. Although we cannot predict the timing and effective date of any future final regulations, ED has indicated an intention to publish a final rule in replacement of the current GE regulations by November 1, 2018, with an effective date of July 1, 2019.

Current GE regulations have three components:

Certification: Institutions must certify that each of their GE programs meet applicable state licensure and accreditation requirements and satisfy applicable educational prerequisites for professional licensure and certification.

Accountability Measures: To maintain Title IV eligibility, GE programs must meet minimum standards for limiting the debt burden versus the earnings of their graduates. GE programs will be considered passing, in the zone, or failing for each year in which the accountability measures are calculated, described as follows:

Pass: Programs whose graduates have an assumed annual loan repayment burden of 8% or less of total earnings or 20% or less of discretionary income.

Zone: Programs that are not passing and whose graduates have an assumed annual loan repayment burden greater than 8% and less than or equal to 12% of total earnings or greater than 20% and less than or equal to 30% of discretionary income.

Fail: Programs whose graduates have an assumed annual loan repayment burden greater than 12% of total earnings and greater than 30% of discretionary income.

Programs that fail in two out of any three consecutive years or do not pass in any four consecutive years will be disqualified from participation in the Title IV programs for a period of three years, and an institution is prohibited from establishing Title IV eligibility for any substantially similar program during that period.

Transparency: Institutions are required to make annual public disclosures regarding the performance and outcomes of their GE programs. The disclosures include information regarding program costs, median debt of all graduates and completion and placement rates and may include additional disclosure items in future periods.

The accountability measures typically weigh a calculated debt burden from graduates who completed their studies three and four years prior to the measuring academic year against the mean or median earnings of these graduates during the most recent calendar year prior to the conclusion of the measuring academic year. Thus, for the 2014-2015 academic year (the first measurement year under these regulations), the cohort includes graduates from the 2010-2011 and 2011-2012 academic years and earnings for these graduates from calendar year 2014. ED obtained its graduate earnings data from the Social Security Administration. Debt burdens for students enrolled in programs that require an internship or residency prior to licensure, such as the medical doctor degrees offered by AUC and RUSM, are calculated from cohorts who completed their studies six and seven years prior to the measuring academic year.

Final accountability measures for the 2014-2015 academic year were released to institutions on January 8, 2017. The table below provides a summary of the percentage of total student enrollment at Adtalem Title IV-participating reporting segments and the DeVry University discontinued operations by GE program classification for each of our Title IV-participating reporting segments and discontinued operations, based on student enrollment as of December 31, 2017. Adtalem provided required warnings in February 2017, to enrolled and prospective students with respect to GE programs considered under the regulations to be in jeopardy of losing Title IV eligibility.

Reporting Segment

Passing

Programs

Zone

Failing without a

Status (1)

Medical and Healthcare

94%

4%

0%

2%

U.S. Traditional Postsecondary

78%

14%

8%

Discontinued Operations

61%

3%

22%

(1)

Programs without a Status include those without enough graduates to calculate a debt to earnings measure, or programs launched after the 2014-15 measurement year.

The table below provides a summary of Title IV revenue (in thousands) by GE program classification at Adtalem Title IV participating reporting segments and the DeVry University discontinued operations from programs impacted by GE based on the 2014-2015 academic year accountability measures.

Zone Programs

Failing Programs

Fiscal Year

2017

Six Months Ended 12/31/17

$

75,000

37,000

-

16,000

6,000

84,000

33,000

19,000

4,000

Information regarding each of the programs affected by GE based on the 2014-2015 academic year measures, including the percentage of students enrolled in Adtalem Title IV-participating programs and a summary of adjustments and initiatives taken for such program is set forth below:

Institution

Program

GE Status

Actions Implemented

Medical and Healthcare Segment

Ross University School of Veterinary Medicine

Doctor of Veterinary Medicine

Debt repayment under consideration

Carrington College-California

Medical Administrative Assistant, Certificate

Tuition reduction effective October 2017

Medical Administrative Assistant, Associate

Fail

New student enrollment ceased; teach out completed in June 2017

Medical Assisting, Associate

Pharmacy Technology, Associate

Veterinary Technology, Associate

Developing new program

Criminal Justice, Associate

Carrington College-Phoenix

Message Therapy, Certificate

Carrington College-Boise

Dental Assisting, Associate

New student enrollment ceased; teach out completed in February 2017

DeVry University

Associate Electronics & Computer Technology

Tuition reduction effective July 1, 2017

Associate Health Information Technology

Associate Accounting

New student enrollment ceased in November 2016; existing students completing program

Associate Web Graphic Design

Bachelor Business Administration

Counseling students into lower cost programs

Bachelor Multimedia Design & Development

Tuition reduction effective July 1, 2017; created stackable certificate program to permit earnings increase prior to graduation and lower resulting indebtedness

Management is closely monitoring ED’s negotiated rulemaking process and, based on draft regulatory summaries released by ED during negotiating sessions, believes that the GE regulations will be substantially revised to eliminate loss of Title IV eligibility as a GE sanction or adjust it for graduate programs. Management expects RUSVM will continue to be in the zone for the 2015-2016 and 2016-2017 academic years. This is possible notwithstanding strong student outcomes and very low Cohort Default Rates for RUSVM graduates (0.2% for FY14, the latest 3-year cohort period for which official data is available). If the GE regulations and guidance are not changed prior to 2019 and RUSVM’s veterinary program is determined by ED to be in the zone for the 2015-2016 and 2016-2017 academic years, RUSVM would be required to issue warnings to students as early as 2019 that Title IV funding may no longer be available to students attending RUSVM. Management may seek to reduce RUSVM student indebtedness for the 2017-2018 academic year to avoid a zone determination for that academic year in the event a favorable outcome from the current rulemaking process is not anticipated. If the GE rule is unchanged and RUSVM’s veterinary program is determined to be in the zone for the 2017-2018 academic year, RUSVM students would no longer have access to Title IV student aid as early as the beginning of 2020, which could have a material adverse effect on the business, financial condition, results of operations and cash flows.

Read in the reply
In its next report

First report after the company's reply of Apr 11, 2018: 10-Q filed May 3, 2018 ↗, against the 10-Q filed Feb 6, 2018 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Liquidity and Capital Resources · Financial Aid, page 53
SEC asked (3)
We note your disclosure on page 55 that in September 2016, you committed to voluntarily limit the amount of revenue that each of your six Title IV institutions derive from federal funding to 85%. Disclose the reason the Company implemented this self-imposed limitation.
CVSA answered
On September 20, 2016, Adtalem announced in a press release that it would voluntarily limit the amount of revenue that each of its six Title IV institutions derive from federal funding to 85 percent, including Department of Veterans Affairs (“VA”) and military tuition assistance benefits.

Current federal regulations allow for-profit higher education institutions to derive 90 percent of their revenue from Title IV federal student aid. VA and other military tuition assistance benefits are not included in the 90 percent calculation.
Rest of the answer

Under the new plan, Adtalem’s institutions will receive no more than 85 percent of revenue from federal student aid, including VA and military benefits.

Additionally, on October 31, 2016, Adtalem announced in a press release the adoption of an expanded set of student commitments, including specific measures to promote responsible recruitment and enrollment, successful student outcomes, and informed student choice. In all, these voluntary student commitments build upon strong existing practices and take Adtalem institutions above and beyond standard higher education policies and practices. Adtalem also committed to refreshing these voluntary student commitments annually, and publicly report on its implementation of the voluntary commitments.

Adtalem committed to finding solutions to the issues facing higher education. Management believes students deserve greater transparency to make informed choices about their education. Management also aims to provide all stakeholders with greater visibility into our student services, outcomes and financial stewardship. These student commitments build upon a solid foundation and bring Adtalem to a new level of public accountability.

Adtalem’s “Student Commitments” include the commitment to lower the limit on federal funding (including VA and military tuition assistance benefits) to 85 percent of revenue at Adtalem’s six Title IV institutions and to prohibit mandatory arbitration. Among the additional commitments are the following:

Informed student choice: help students make informed decisions through a one-page disclosure that includes such metrics as total program costs, debt and default rates, completion and graduation rates, and earnings and licensure data.

Financial literacy: provide proactive financial counseling in-person and via access to Manage My Loans, a dynamic online tool; and a new borrowing advisory notice. These tools will give students ongoing visibility into their financial position compared to their academic progress and credits required to graduate, among other measures.

Recruitment and enrollment transparency: benchmark and disclose recruiting expenditures against national standards, transparency in the use of revenues for marketing, instruction and academic support, student services and scholarships; and recording of admissions conversations in order to ensure compliance with laws and regulations.

Successful student outcomes: management is developing solutions to improve student learning, persistence and graduation, and forming actionable strategies to deal effectively with the issues of affordability and value.

We are providing an example of our future disclosures based upon our most recent filing to be responsive to the SEC's comments regarding the Financial Aid discussion in the MD&A, Liquidity and Capital Resources section. We intend to include this language in the MD&A, Liquidity and Capital Resources disclosures in future filings.

In September 2016, Adtalem committed to voluntarily limit to 85% the amount of revenue that each of its six Title IV-eligible institutions derive from federal funding, including the U.S. Department of Veterans Affairs and military tuition assistance benefits. As disclosed in the third party review report that has been made publicly available, its institutions have met this lower threshold for fiscal year 2017. Adtalem is committed to implementing measures to promote responsible recruitment and enrollment, successful student outcomes, and informed student choice. Management believes students deserve greater transparency to make informed choices about their education. This commitment builds upon a solid foundation and brings Adtalem to a new level of public accountability.

Read in the reply
In its next report

First report after the company's reply of Apr 11, 2018: 10-Q filed May 3, 2018 ↗, against the 10-Q filed Feb 6, 2018 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Also in this review: closing letter, 2018-04-12

Form 10-K

2017-01-25 to 2017-02-08 · 2 questions · 1 letter from the SEC, 1 from the company
Review closed 2017-02-08
RevenueSegmentsResults discussion (MD&A)
SEC asked (1)
Please enhance your discussion of the known trends, events, or uncertainties that have had or will have materially favorable or unfavorable impacts on the results of your operations in your Business, Technology and Management (BTM) segment.
Rest of the question

Specifically, please discuss factors including enrollment, tuition, regulatory changes, competition, and the economic environment that have impacted and are expected to impact your future results of operations for the BTM segment. In this regard, we note that the revenues in your Business, Technology, and Management segment have declined by 23% and you anticipate continued declines in fiscal year 2017. Please refer to Commission Release No. 33-8350.

CVSA answered
DeVry Group’s Response

An introductory discussion of DeVry Group’s consolidated revenues begins on page 64 of the Form 10-K for Fiscal Year Ended June 30, 2016, and includes a general discussion of segment and institution component increases and decreases in revenue. A more detailed discussion of DeVry University’s revenue results is on pages 68-70 of the Form 10-K.
Rest of the answer

In our Quarterly Report on Form 10-Q for the Quarterly Period Ended December 31, 2016, filed on February 2, 2017, we have revised the revenue introductory discussion to read as follows with the bold sentence added in order to direct the reader to the more detailed discussions in the sub-section specifically related to the Business, Technology and Management segment. We intend to include this additional language in the MD&A disclosures in all future filings.

DeVry Education Group • 3005 Highland Parkway • Downers Grove, IL 60515 • 630.515.7700 • devryeducationgroup.com

REVENUE

Total consolidated revenue for the second quarter of fiscal year 2017 of $456.4 million increased $0.1 million as compared to the year-ago quarter. For the first six months of fiscal year 2017, total consolidated revenue increased $8.6 million or 1.0% to $906.2 million, as compared to the year-ago period. Included in the second quarter and first six months of fiscal year 2017 revenue is $31.0 million and $60.5 million, respectively, related to the fiscal year 2017 acquisition of Association of Anti-Money Laundering Specialists (“ACAMS”) and acquisitions at DeVry Educacional do Brasil (“DeVry Brasil”) of Grupo Ibmec Educacional S.A. (“Grupo Ibmec”) which occurred late in the second quarter of fiscal year 2016 and Faculdade de Imperatriz (“Facimp”) which occurred in the fourth quarter of fiscal year 2016. Excluding the effect of the increase in value of the Brazilian Real as compared to the U.S dollar of $7.2 million and $11.7 million, total consolidated revenue decreased 1.5% and 0.3%, as compared to the year-ago quarter and six-month period, respectively. Constant currency calculations assume conversions of local currency amounts at exchange rates in effect in the year-ago period as compared to those conversions at exchange rates in effect during the current fiscal year period. On a constant currency basis, revenue declines in the second quarter and first six months of fiscal year 2017 were driven by revenue declines at DeVry University of 23.6% and 23.9%, as compared to the year-ago quarter and six-month period, respectively, driven by a decline in total student enrollment. Within the Medical and Healthcare segment, revenue declined 0.2% in the second quarter of fiscal year 2017, as compared to the year-ago quarter, driven by declines in student enrollment at Carrington and DeVry Medical International (“DMI”), which offset enrollment increases at Chamberlain, but revenue rose by 2.7% for the first six months of fiscal year 2017, as compared to the year-ago period, driven by growth in total student enrollment at Chamberlain and tuition price increases at DMI. Revenue also rose within the International and Professional Education segment on a constant currency basis, including the acquisitions noted above, by 49.9% and 50.4%, as compared to the year-ago quarter and six-month period, respectively, which partially offset the revenue declines in the other segments. Revenue results by segment are discussed in more detail in the sections below.

Management expects that for the third quarter of fiscal year 2017, revenue will be down 3 to 4 percent as compared to the third quarter of fiscal year 2016. For the full fiscal year 2017, revenue is expected to be flat to down approximately 1 percent compared to the prior fiscal year. Revenue growth within the International and Professional Education and Medical and Healthcare segments along with the expected higher value compared to the prior year of the Brazilian Real as compared to the U.S. dollar are expected to be offset by DeVry University’s continuing planned revenue declines resulting from the impact of lower new and total student enrollments.

In our Quarterly Report on Form 10-Q for the Quarterly Period Ended December 31, 2016, filed on February 2, 2017, our detailed discussion of DeVry University’s revenue results has been revised as follows in response to your requests in this comment. We intend to include this additional detail in the MD&A disclosures in all future filings when discussing DeVry University revenue.

Business, Technology and Management

Revenue in the Business, Technology and Management segment, which is composed solely of DeVry University, decreased 23.6% to $122.4 million in the second quarter and decreased 23.9% to $243.3 million for the first six months of fiscal year 2017, as compared to the year-ago periods, as a result of a decline in student enrollment as DeVry University repositions itself to stabilize enrollment. Enrollment declines are expected to continue for the remainder of fiscal year 2017, which will result in lower revenue. Increased discounting and use of scholarships have also contributed to the decline in revenue. Key trends in revenue, enrollment and tuition pricing are set forth below.

DeVry University Undergraduate Student Enrollment:

Fiscal Year 2017

Term

July 2016

Sept. 2016

Nov. 2016

Jan. 2017

New Students

2,953

3,432

3,092

2,528

% Change over Prior Year

(26.2%

)

(14.3%

7.2%

(16.7%

Total Students

24,213

24,540

24,015

22,994

(22.6%

(22.9%

(20.3%

(21.6%

Fiscal Year 2016

July 2015

Sept. 2015

Nov. 2015

Jan. 2016

Mar. 2016

May 2016

4,000

4,006

2,883

3,036

2,970

2,982

(18.6%

(24.0%

(31.4%

(29.1%

(28.5%

(21.9%

31,293

31,843

30,132

29,313

28,069

26,492

(15.9%

(20.1%

(21.2%

(22.7%

(22.4%

(23.3%

DeVry University Graduate Student Enrollment:

Total Coursetakers

9,742

10,146

9,589

9,553

% Change from Prior Year

(19.4%

(23.1%

(22.8%

12,084

12,937

12,463

12,368

11,699

10,810

(12.7%

(17.7%

(18.1%

(21.7%

The term “coursetaker” refers to the number of courses taken by a student. Thus, one student taking two courses is counted as two coursetakers.

DeVry University new undergraduate student enrollment increased 7.2% for the November 2016 session as compared to the same session last year. This increase was principally the result of former students of ITT Educational Services enrolling in DeVry University programs after it ceased operations. For the January 2017 session, new undergraduate student enrollment declined 16.7% as compared to the same session last year.

Tuition Rates:

·

For fiscal year 2017, DeVry University’s U.S. undergraduate tuition is $609 per credit hour for new students. If a student was enrolled before September 2015, they will continue to pay $609 per credit hour for up to seven credit hours and $365 for each credit hour in excess of seven credit hours as they are covered under DeVry University’s Fixed Tuition Promise (“FTP”). DeVry University has frozen both undergraduate and graduate tuition for the past several years. These amounts do not include the cost of books, supplies, transportation and living expenses.

For fiscal year 2017, Keller Graduate School of Management (“Keller”) program tuition per course is $2,298. This rate is unchanged from the prior year.

Any tuition rate increases after July 2017 will apply only to newly enrolled students. Existing students will pay the tuition they were paying at the time DeVry University adopted its FTP or, if later, at the time of their enrollment. To remain eligible for the FTP students may not miss more than five consecutive sessions.

Management believes the decreases in undergraduate and graduate enrollment and the resulting continued decline in revenue have been due to several factors which have resulted in a reduction in interest and lower demand for DeVry University’s programs, including the following:

Heightened competition from both public and private-sector education providers. Management believes heightened competition at the local level has increased, as traditional four-year colleges are targeting adult students, DeVry University’s largest student segment, to a much greater extent. In addition, public-sector and independent colleges are taking share from national competitors.

Our competitors offer programs and degrees at a lower price than DeVry University. While students appear willing to pay a higher price for private independent colleges, DeVry University is more expensive than many of its public and private-sector competitors. This has resulted in increasing pricing pressure which hinders revenue growth. DeVry University has not raised it’s per credit hour tuition since July 2012 and does not anticipate having the ability to raise prices in the near-term.

Regulatory and other legal actions and the claims contained in these actions may have diminished DeVry University’s reputation in the education sector. These actions and the resulting negative publicity may have decreased interest by potential students. Management believes the settlement of the FTC litigation and our denying of all wrongdoing should enable DeVry University to alleviate potential student concerns; however, we cannot quantify how this may affect future enrollment.

The regulatory environment in which DeVry University currently operates and the national attention on the for-profit education industry, including the failure of several high profile competitors, hinders our ability to attract new students which is expected to continue into the foreseeable future.

The state of the general economic environment has had an impact on price sensitivity and the ability and willingness of students to incur debt to finance their education. Also, during periods when unemployment rates decline or remain stable, as in recent years, prospective students have more employment options and may forgo or delay obtaining a postsecondary education.

New student enrollment declines will continue to drive down total student enrollment which will result in revenue declines on the magnitude of the percentage declines in total students. To address the issue of declining enrollment, DeVry University is focused on implementing management’s transformation strategy, which includes both near-term actions to stabilize enrollments and sustain positive economics and longer-term investments to increase competitiveness and differentiation. Management’s plans include attracting additional new students and improving the persistence of existing students. Over the long-term, management’s goal is to transform DeVry University by improving the student experience and programs, addressing affordability and improving awareness of the university’s programs. Management expects to accomplish this with more efficient marketing, launching new, flexible programs, creating shorter programs, creating certificate programs, deploying a new student-centric scheduling system, optimizing the pricing structure and the use of scholarships, and increasing focus on corporate and employer relationships. Indicative of our efforts to improve enrollment is the launch of the “DeVry Tech” initiative in January 2017. This initiative infuses a foundation of technology skills, or “Tech Path,” into all of DeVry University program offerings. Whether a student is taking a healthcare program, a business program or a technology program, they will graduate with not only an expertise in their chosen major, but also a strong foundation of technology skills that will help them bring together people, processes, data and devices to help solve business problems for their employer. Management believes this approach will further establish a reputation for DeVry University graduates as highly valued employees recognized for using technology to solve problems.

Read in the reply
DeVry University Undergraduate and Graduate Student Enrollment, page 69
SEC asked (2)
Please enhance your discussion of management’s plans to further align the cost structure and increase efficiencies by incorporating more specific plans of how you intend to implement these cost-saving measures including the closure and consolidation of additional campuses of DeVry University. Please refer to Commission Release No. 338350.
CVSA answered
In our Quarterly Report on Form 10-Q for the Quarterly Period Ended December 31, 2016, filed on February 2, 2017, our discussion of DeVry University’s plans to further align the cost structure to match revenue declines has been revised as follows in response to your request in this comment. We intend to include this additional detail in the MD&A disclosures in all future filings when discussing DeVry University cost reduction efforts.

DeVry University enrollment declines have reduced revenue by almost 50% since fiscal year 2014.
Rest of the answer

In response, management has focused on increasing cost efficiencies and has reduced costs by approximately 48% over this time period through the following methods:

Analyzing facility usage requirements and rightsizing the DeVry University footprint in each market in which it operates. Management made the decision to close or consolidate certain DeVry University campuses while balancing the potential impact on enrollment and student satisfaction. Since the beginning of fiscal year 2014, DeVry University has closed 39 campus locations and completed additional campus size reductions. This is expected to result in full fiscal year 2017 facility costs that are approximately $34 million, or 45%, lower compared to fiscal year 2014. As of the commencement of the January 2017 session, DeVry University operates 60 campus locations. No further campus closures are currently anticipated; however, management has made the decision to sell the DeVry University owned facility in Pomona, California and is intending to remain in this market in a smaller leased space. Management is also currently renegotiating leases in several other markets to reduce space and lower future operating costs.

Optimizing course scheduling to better utilize classrooms and faculty and simplifying program offerings. The average class size at DeVry University has increased from historical levels of 17 students to 20.5 students in fiscal year 2017.

Adjusting staffing and management structure within DeVry University. Total full-time faculty and administrative headcount at DeVry University has decreased from 2,595 in fiscal year 2014 to 1,270 in fiscal year 2017. Direct cost of instruction labor costs are expected to be approximately 58% lower in fiscal year 2017 as compared to fiscal year 2014. This process of adjusting staffing costs will continue into the near-term as management continually evaluates needs based on enrollment trends. This may result in future staff reductions as well as management realignment. DeVry Group home office administration costs have also been reduced and will continue to be evaluated based on the need to support a smaller DeVry University organization. Home office costs allocated to DeVry University have declined approximately 29% for the first six months of fiscal year 2017, compared to the year-ago six-month period.

Managing advertising expenditures. In the second quarter of fiscal year 2017, management reduced advertising expense by $10 million as compared to the second quarter of fiscal year 2016. Advertising expense in the second half of fiscal year 2017 is expected to decline as well, but at a lower rate.

Read in the reply
In its next report

First report after the company's reply of Feb 7, 2017: 10-Q filed May 4, 2017 ↗.

No earlier 10-Q before the SEC's letter is in Tickdelta, so there is nothing to compare with.

Also in this review: closing letter, 2017-02-08

From the SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), 16 letters filed since 2017-01-25. Questions and answers are matched by their numbers; topics come from words in each question. The reports are compared word for word (same form, before the first SEC letter against the first report after the company's reply). No AI.

Sources

The SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), matched question by question. No AI.

Also

Filings: the letters in the filing list.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CVSA/export.csv") into a cell.

Next in Owners and insiders:Insider trades
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.